BC
ELV icon

Beaconlight Capital’s Elevance Health ELV Stock Holding History

Beaconlight Capital’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-32,400
Closed -$7.36M – 36
2020
Q1 		$7.36M Buy
+32,400
New +$8.83M 1.96% 16
2018
Q4 		– Sell
-32,215
Closed -$8.83M – 33
2018
Q3 		$8.83M Sell
32,215
-22,435
-41% -$5.82M 2.88% 11
2018
Q2 		$13M Buy
+54,650
New +$12.7M 4.87% 8
2018
Q1 		– Sell
-17,468
Closed -$3.93M – 21
2017
Q4 		$3.93M Buy
17,468
+9,268
+113% +$1.97M 1.44% 18
2017
Q3 		$1.56M Sell
8,200
-15,600
-66% -$2.97M 0.82% 16
2017
Q2 		$4.48M Sell
23,800
-13,900
-37% -$2.5M 3.6% 9
2017
Q1 		$6.24M Buy
+37,700
New +$6M 3.96% 11

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Beaconlight Capital's ELV Position: Q2 2020 in Review

Beaconlight Capital sold out of Elevance Health (ELV) in Q2 2020, closing a stake of 32,400 shares — an estimated $7.36M sold.

Beaconlight Capital first reported a position in ELV in Q1 2017 and held it in 7 quarters. The position peaked at $13M in Q2 2018. 1,107 funds tracked by Wall St. Rank hold ELV as of Q2 2020.

  • Beaconlight Capital reported no remaining Elevance Health position as of Q2 2020 after selling out during the quarter.
  • Beaconlight Capital sold 32,400 Elevance Health shares in Q2 2020, an estimated $7.36M.
  • Beaconlight Capital first reported a position in Elevance Health in Q1 2017 and held it in 7 quarters.
  • Beaconlight Capital's Elevance Health position peaked at $13M in Q2 2018.
  • 1,107 funds tracked by Wall St. Rank held Elevance Health as of Q2 2020.

Based on Beaconlight Capital's 13F filing for Q2 2020, filed 14 Aug 2020.